1. EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells
    Nina Mallmann-Gottschalk et al, 2019, International Journal of Molecular Sciences CrossRef
  2. Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting
    Kristina Westerlund et al, 2019, Biomaterials CrossRef
  3. Comparing the measured affinity of 111In-labeled ligands for cellular receptors by monitoring gamma, beta, or X-ray radiation with three different LigandTracer® devices
    Zohreh Varasteh et al, 2015, Journal of Radioanalytical and Nuclear Chemistry CrossRef
  4. Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label
    Sarah Lindbo et al, 2018, Journal of Nuclear Medicine CrossRef
  5. Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression
    Maria Rosestedt et al, 2017, International Journal of Oncology CrossRef
  6. Erlotinib/hydroxypropyl-β-cyclodextrin inclusion complex: characterization and in vitro and in vivo evaluation
    Sávio M. L. Gontijo et al, 2015, Journal of Inclusion Phenomena and Macrocyclic Chemistry CrossRef
  7. Protein–protein interactions between SWCNT/chitosan/EGF and EGF receptor: a model of drug delivery system
    Chompoonut Rungnim et al, 2016, Journal of Biomolecular Structure and Dynamics CrossRef
  8. Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties
    Sergey Deyev et al, 2019, Molecular Pharmaceutics CrossRef
  9. New approaches for the reliable in vitro assessment of binding affinity based on high-resolution real-time data acquisition of radioligand-receptor binding kinetics
    Markus Zeilinger et al, 2017, EJNMMI Research CrossRef
  10. Relationship between the agonist activity of synthetic ligands of TRAIL-R2 and their cell surface binding modes
    Neila Chekkat et al, 2018, Oncotarget CrossRef
  11. Detecting ligand interactions with G protein-coupled receptors in real-time on living cells
    Bo Xu et al, 2013, Biochemical and Biophysical Research Communications CrossRef
  12. The complexities of PKCα signaling in cancer
    Adrian R. Black et al, 2021, Advances in Biological Regulation CrossRef
  13. Differential effects of epidermal growth factor receptor inhibitors in a single patient with neuropathic pain
    Marte Grønlie Cameron et al, 2021, BMJ Case Reports CrossRef
  14. Synthesis and photophysical properties of a fluorescent cyanoquinoline probe for profiling ERBB2 kinase inhibitor response
    Heajin Lee et al, 2017, Bioorganic & Medicinal Chemistry CrossRef
  15. A conformational sensor based on genetic code expansion reveals an autocatalytic component in EGFR activation
    Martin Baumdick et al, 2018, Nature Communications CrossRef
  16. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors
    Dima A. Sabbah et al, 2020, Current Topics in Medicinal Chemistry CrossRef
  17. Conjugation Effects on Antibody–Drug Conjugates: Evaluation of Interaction Kinetics in Real Time on Living Cells
    Sina Bondza et al, 2014, Molecular Pharmaceutics CrossRef
  18. Transfer of Dyes and Drugs into Cells Using EGFR-Targeted Nanosyringes
    Lizanne G. Nilewski et al, 2018, ACS Chemical Neuroscience CrossRef
  19. Synthesis of Diagnostic Silicon Nanoparticles for Targeted Delivery of Thiourea to Epidermal Growth Factor Receptor-Expressing Cancer Cells
    Mehrnaz Behray et al, 2016, ACS Applied Materials & Interfaces CrossRef
  20. Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors
    Anzhelika Vorobyeva et al, 2018, Contrast Media & Molecular Imaging CrossRef